NBIX: Neurocrine Biosciences, Inc. Stock

by  •  • Comments Off on NBIX: Neurocrine Biosciences, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 10,974.37
Enterprise Value ($M) 9,898.27
Book Value ($M) 2,589.70
Book Value / Share 25.97
Price / Book 4.24
NCAV ($M) 595.70
NCAV / Share 5.97
Price / NCAV 18.42

Profitability (mra)
Return on Invested Capital (ROIC) 0.11
Return on Assets (ROA) 0.10
Return on Equity (ROE) 0.15

Liquidity (mrq)
Quick Ratio 3.28
Current Ratio 3.40

Balance Sheet (mrq) ($M)
Current Assets 1,724.70
Assets 3,718.70
Liabilities 1,129.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,355.30
Operating Income 583.00
Net Income 341.30
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 595.40
Cash from Investing -126.80
Cash from Financing -486.70

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-06 13G/A Vanguard Group Inc 10.15 4.32
02-05 13G State Street Corp 4.80 -4.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-21 332,958 1,147,274 29.02
2025-03-20 210,692 713,067 29.55
2025-03-19 175,559 718,385 24.44
2025-03-18 202,506 879,330 23.03
2025-03-17 212,919 698,643 30.48

(click for more detail)

Similar Companies
MRSN – Mersana Therapeutics, Inc. MRVI – Maravai LifeSciences Holdings, Inc.
MYGN – Myriad Genetics, Inc. NEOG – Neogen Corporation
NKTX – Nkarta, Inc.


Financial data and stock pages provided by
Fintel.io